Cowen And Company, LLC Atreca, Inc. Transaction History
Cowen And Company, LLC
- $3.91 Billion
- Q2 2024
A detailed history of Cowen And Company, LLC transactions in Atreca, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 32,200 shares of BCEL stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,200Holding current value
$0% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BCEL
# of Institutions
2Shares Held
30.6KCall Options Held
0Put Options Held
0About Atreca, Inc.
- Ticker BCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 31,876,000
- Description
- Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...